Pro-41

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePro-41
Drug Alias Nameimmunostimulant gene therapy (Protiva)
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProtiva Biotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProtiva Biotherapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A